Publique un comentario 
Fitoterapia de la Medicina Tradicional China para combatir de forma exitosa la covid-19
Texto completo:
PDFResumen
Introducción: COVID-19 es una nueva enfermedad que se origina en China en noviembre del año 2019. La enfermedad es producida por un tipo de coronavirus, identificado como Sars-Cov-2. Objetivo: describir el uso de la fitoterapia de la Medicina Tradicional China en el tratamiento de covid-19 en California durante 2020. Método: se realizó un estudio descriptivo de corte transversal con 50 pacientes del estado de California, tratados para el covid-19 con   fitoterapia de la Medicina Tradicional China. Se cumplió con los principios éticos y la confidencialidad de los datos. Se operacionalizaron variables que dieron salida al objetivo planteado. Se resumieron las variables con medidas de frecuencia absolutas y relativas, las cuales fueron representadas de forma tabular. Resultados: El 64% del grupo estudiado era masculino, de forma general predominó el grupo de 50-59 años. Al 58% se les realizó PCR y la totalidad dio positivo. Predominó la fiebre y el malestar general en más de la mitad de los pacientes estudiados. El factor de riesgo observado con mayor frecuencia fue el sobrepeso. El 80% tomó infusiones durante los sÃntomas, mientras que el 82% se recuperó en menos de una semana. Conclusiones: la endemia causada por el virus SARS-CoV sufrida en China entre los años 2 002 y 2 003 dio lugar a reportes sobre la eficacia de la MTC ancestral. Eso sirvió como base para combatir la pandemia causada por el SARS-CoV-2 en los pacientes tratados con esta terapia alternativa, lográndose resultados favorables.
Palabras clave
Referencias
WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. Who.int. [cited 2021 May 16]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
China releases genetic data on new coronavirus, now deadly [Internet]. Umn.edu. [cited 2021 May 16]. Available from: https://www.cidrap.umn.edu/news-perspective/2020/01/china-releases-genetic-data-new-coronavirus-now-deadly
Cdc.gov. [cited 2021 May 14]. Available from: https://www.cdc.gov/flu/symptoms/flu-vs-covid19.html
COVID-19 and gender monitor [Internet]. Unwomen.org. [cited 2021 May 15]. Available from: https://data.unwomen.org/resources/covid-19-and-gender-monitor
de Paz C, Muller M, Munoz Boudet AM, Gaddis I. Gender dimensions of the COVID-19 pandemic. World Bank, Washington, DC; 2020.
Coronavirus: the science explained-UKRI. Sex, gender and COVID-19 [Internet]. Ukri.org. [cited 2021 May 16]. Available from: https://coronavirusexplained.ukri.org/en/article/cad0007/
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.
Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health. 2020;8:152.
Fda.gov. [cited 2021 May 15]. Available from: https://www.fda.gov/media/134922/download
Thevaccinereaction.org. [cited 2021 May 15]. Available from: https://thevaccinereaction.org/2020/11/understanding-pcr-tests-for-coronavirus/
970Universal.com. [cited 2021 May 15]. Available from: https://970universal.com/2021/02/10/dr-sciuto-no-hay-forma-de-diferenciar-el-covid-19-de-un-resfrio/
Smith C. French coronavirus variant can’t be detected by PCR tests [Internet]. Bgr.com. BGR; 2021 [cited 2021 May 16]. Available from: https://bgr.com/tech/coronavirus-french-mutation-undetected-pcr-test-5913752/
Cdc.gov. [cited 2021 May 15]. Available from: https://www.cdc.gov/flu/symptoms/coldflu.html
Yang W, Chen X, Li Y, Guo S, Wang Z, Yu X. Advances in pharmacological activities of terpenoids. Nat Prod Commun. 2020;15(3):1934578X2090355.
Choudhry N, Zhao X, Xu D, Zanin M, Chen W, Yang Z, et al. Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). J Med Chem. 2020;63(22):13205–27.
Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, et al. Discovery of a novel inhibitor of Coronavirus 3CL protease as a clinical candidate for the potential treatment of COVID-19. bioRxivorg [Internet]. 2020; Available from: http://dx.doi.org/10.1101/2020.09.12.293498
Khalil AA, Rahman U ur, Khan MR, Sahar A, Mehmood T, Khan M. Essential oil eugenol: sources, extraction techniques and nutraceutical perspectives. RSC Adv. 2017;7(52):32669–81.
Huang M-Z, Yang Y-J, Liu X-W, Qin Z, Li J-Y. Aspirin eugenol ester attenuates oxidative injury of vascular endothelial cells by regulating NOS and Nrf2 signaling pathways. Br J Pharmacol. 2019;176(7):906–18.
Ma N, Liu X-W, Yang Y-J, Li J-Y, Mohamed I, Liu G-R, et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model. PLoS One. 2015;10(7):e0133125.
da Silva FFM, Monte FJQ, de Lemos TLG, do Nascimento PGG, de Medeiros Costa AK, de Paiva LMM. Eugenol derivatives: synthesis, characterization, and evaluation of antibacterial and antioxidant activities. Chem Cent J [Internet]. 2018;12(1). Available from: http://dx.doi.org/10.1186/s13065-018-0407-4
Kim K, Park K-I. A review of antiplatelet activity of traditional medicinal herbs on integrative medicine studies. Evid Based Complement Alternat Med. 2019;2019:7125162.
Zhang C, Fan L, Fan S, Wang J, Luo T, Tang Y, et al. Cinnamomum cassia Presl: A review of its traditional uses, phytochemistry, pharmacology and toxicology. Molecules. 2019;24(19):3473.
globalnewscommunication. Riconoscimenti dal Mondo sulle ricerche del cardiologo italiano, Giampaolo Palma, su Malattia Coagulativa da Covid-19 [Internet]. Altervista.org. 2020 [cited 2021 May 16]. Available from: http://globalnewscommunication.altervista.org/2020/05/14/riconoscimenti-dal-mondo-sulle-ricerche-del-cardiologo-italiano-giampaolo-palma-su-malattia-coagulativa-da-covid-19/
Aiello V. Le autopsie (che il Ministero non voleva) rivelano la causa di morte dei pazienti con coronavirus [Internet]. Scienze fanpage. 2020 [cited 2021 May 18]. Available from: https://scienze.fanpage.it/le-autopsie-che-il-ministero-non-voleva-rivelano-la-causa-di-morte-dei-pazienti-con-coronavirus/
Singh NA, Kumar P, Jyoti, Kumar N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19. Phytother Res [Internet]. 2021;(ptr.7019). Available from: http://dx.doi.org/10.1002/ptr.7019
Parham S, Kharazi AZ, Bakhsheshi-Rad HR, Nur H, Ismail AF, Sharif S, et al. Antioxidant, antimicrobial and antiviral properties of herbal materials. Antioxidants (Basel). 2020;9(12):1309.
Goswami D, Kumar M, Ghosh SK, Das A. Natural Product Compounds in Alpinia officinarum and Ginger are Potent SARS-CoV-2 Papain-like Protease Inhibitors [Internet]. ChemRxiv. 2020. Available from: http://dx.doi.org/10.26434/chemrxiv.12071997
Plantsjournal.com. [cited 2021 May 15]. Available from: https://www.plantsjournal.com/archives/2018/vol6issue2/PartC/6-2-42-182.pdf
Tran HTT, Le NPK, Gigl M, Dawid C, Lamy E. Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro [Internet]. bioRxiv. 2021. Available from: http://dx.doi.org/10.1101/2021.03.19.435959
Virologyj.com. [cited 2021 May 15]. Available from: http://www.virologyj.com/content/8/1/538
Bitz B. Covid -19, Coronavirus: Herbal Classes based on the Viral Process [Internet]. Weeds & Wildflowers. 2020 [cited 2021 May 15]. Available from: https://medium.com/weeds-wildflowers/covid-19-coronavirus-potential-herbal-protocol-d06a43017ebe
Covid- 19: Coronavirus, potential herbal protocol - Google drive [Internet]. Google.com. [cited 2021 May 15]. Available from: https://docs.google.com/spreadsheets/d/e/2PACX-1vSU2F5ePoL1QFEZJx2N1BMESlZuQM5LoBdgtE2UTPlR2DohPy59RJ5ZySouoyAnpY3wWq1THMNwwxH4/pubhtml
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2021 Alland Meyer Letona, Miday Columbié Pileta, Arturo Rolando Piedrasanta
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.
La revista está: Certificada por el CITMA